Skip to main content
Premium Trial:

Request an Annual Quote

Micro-Macinazione USA, bioRASI, Lowe Enterprises, O’Connor Capital Partners, Gutierrez Co.

Premium
Swiss Clinical Manufacturer Expanding Into US With New Tarrytown, NY, Facility
 
The US subsidiary of a Swiss clinical manufacturer serving the biopharma industry has chosen New York over New Jersey for the site of a new micronization facility it plans to open in the US.
 
Micro-Macinazione USA plans to lease 10,000 square feet within The Landmark at Eastview, a 750,000-square-foot Tarrytown, NY, office-lab campus operated by BioMed Realty Trust.
 
Salvatore Carrera, Westchester’s director of economic development/real estate, told BioRegion News the company is seeking an exemption from state and county sales taxes on construction materials valued at $100,000. In return, it has promised to create at least 10 jobs in Tarrytown. The company has projected the cost of the Tarrytown project at $5 million.
 
Established in 1970, Micro-Macinazione USA is a leading European micronization contractor seeking to expand into the US. The company’s customers now must ship their ingredients to its production facility in Switzerland.
 
General Manager Carl Edelman told the Westchester County (NY) Business Journal that the company considered the site a better place to run its business than one it was considering in Brunswick, NJ. The company grinds bulk ingredients into fine particles for use by biotech and pharma companies for their drugs.
 
Tarrytown is in New York’s Westchester County, where the Industrial development agency on Oct. 4 “induced” the relocation by agreeing in principle to assist Micro-Macinazione USA.
 

 
Russian CRO Selects Hollywood, Fla., for Worldwide Headquarters
 
The Russian contract research organization bioRASI, a strategic initiative of Russian Academy of Sciences, announced Oct. 10 that it selected Hollywood, Fla., as the location for its new worldwide headquarters.
 
The company, a spin-off of the Russian Academy of Sciences, will move into 12,000 square feet at Venture Corporate Park, and plans to grow to 48 employees over the next two years. If it employs at least 45, it can collect a $250,000 qualified target industries business incentive deal the company signed with the city of Hollywood and state of Florida.
 
Created in 2001, bioRASI collaborates with pharmaceutical, biotech and medical-device companies worldwide in clinical research leading to the commercialization of products.
 

 
Charlotte, NC, Had Lowest Downtown Office Vacancy in Q3, Index Reports
 
Charlotte, NC, had the nation’s lowest downtown office vacancy rate during the third quarter, followed by Midtown Manhattan and Boston, according to CB Richard Ellis Group’s United States National Office Vacancy Index for the period.
 
According to the Index, downtown Charlotte had a 2.6-percent vacancy rate, ranking it first in the category three years in a row. Midtown Manhattan followed with a 4.9-percent rate and Boston was third with a 6.1-percent rate.
 
At No. 4 was downtown Manhattan, which had a 6.3-percent rate, and No. 5 was Las Vegas, which posted a 7.4-percent vacancy rate.
 
Meantime, the lowest suburban office market vacancy rate was Honolulu at 6.8 percent, followed by Miami with 7 percent and Orlando at 8.2 percent. Los Angeles nabbed the No. 4 slot with 8.4 percent and Ft. Lauderdale, Fla., closed the fifth spot with an 8.8-percent vacancy rate.
 
Nationwide, overall office vacancy slipped to 12.6 percent from 13.2 percent during the third quarter 2006, according to the Index.
 
Detroit had the highest downtown and suburban vacancy rates, at 27.5 percent and 24.5 percent, respectively.
 

 
Lowe Enterprises, O’Connor Capital Buy Nine Acres in Santa Clara for 215K-Sq-Ft Class A Office Development
 
Lowe Enterprises and O’Connor Capital Partners have acquired two adjacent properties totaling approximately nine acres in Santa Clara, Calif., from Deerfield Realty and Pace Properties for $20.5 million.
 
The sites currently are developed with two older, single-story office/R&D buildings totaling 114,000 square feet. The partnership will “immediately” begin seeking entitlements to redevelop the combined properties into a six-story, 215,000-square-foot Class A office building.
 
“Continued solid job growth and business expansion from a variety of industries including biotechnology … companies are creating demand for top-tier office properties in the South Bay,” Marty Caverly, principal of O’Connor Capital Partners, said in a statement.
 
It is anticipated that the building will be ready for occupancy in mid 2009.
 
Lowe Enterprises will lead the entitlement, planning, and construction for the new development and has hired Korth Sunseri Hagey Architects and The Guzzardo Partnership to develop an initial site plan and conceptual design. CB Richard Ellis has been selected as the leasing broker for the property.
 

 
Overdue Sewage Overhaul in Mass. Stalls Development of 600K-Sq-Ft Office and R&D Complex
 
A Burlington, Mass., real estate developer won't start building a 600,000-square-foot office and research complex in neighboring Marlborough until it secures a tenant for the space, but the company will not be able to sign a lessee without promising a connection to the city's sewer system ¯ which has reached capacity and needs an expensive upgrade, according to a local media report.
 
The Gutierrez Co., one of Marlborough's biggest commercial property owners, has plans to eventually develop about 250 acres of land that could support 2 million square feet of office space ¯ some of it biotech ¯ and some retail establishments, all on the heavily industrial and commercial western section of the city, according to The MetroWest Daily News.
 
"I recognize that upgrading a city's wastewater treatment system is not the sexiest or perhaps the most interesting project, but the reality is that it is a critical piece of Marlborough's infrastructure and essential for continued economic growth,'' Rep. James McGovern (D-3D) told the paper.
 
The Gutierrez Co. plans to spend $41 million to develop a 49-acre parcel on Forest Street, which have been looked at by biotechnology companies and other potential tenants, but which have so far been reluctant to sign, according to the paper, which added that biotechs “use a lot of water and have greater wastewater needs than typical office tenants.”

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.